<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33837088</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>15</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle><i>C9orf72</i>-derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eabg3013</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.abg3013</ELocationID><Abstract><AbstractText>A hexanucleotide repeat expansion in the <i>C9orf72</i> gene is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). How this mutation leads to these neurodegenerative diseases remains unclear. Here, we show using patient stem cell-derived motor neurons that the repeat expansion impairs microtubule-based transport, a process critical for neuronal survival. Cargo transport defects are recapitulated by treating neurons from healthy individuals with proline-arginine and glycine-arginine dipeptide repeats (DPRs) produced from the repeat expansion. Both arginine-rich DPRs similarly inhibit axonal trafficking in adult <i>Drosophila</i> neurons in vivo. Physical interaction studies demonstrate that arginine-rich DPRs associate with motor complexes and the unstructured tubulin tails of microtubules. Single-molecule imaging reveals that microtubule-bound arginine-rich DPRs directly impede translocation of purified dynein and kinesin-1 motor complexes. Collectively, our study implicates inhibitory interactions of arginine-rich DPRs with axonal transport machinery in <i>C9orf72</i>-associated ALS/FTD and thereby points to potential therapeutic strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fumagalli</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9333-926X</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Florence L</ForeName><Initials>FL</Initials><Identifier Source="ORCID">0000-0002-5475-9835</Identifier><AffiliationInfo><Affiliation>Division of Cell Biology, MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeynaems</LastName><ForeName>Steven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9705-9871</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Decker</LastName><ForeName>Mathias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Arpan R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0002-5715-5025</Identifier><AffiliationInfo><Affiliation>UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Euan MacDonald Centre, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swijsen</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fazal</LastName><ForeName>Raheem</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8833-9997</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Wenting</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-3585-7728</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Development and Regeneration, Stem Cell Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moisse</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8880-9311</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beckers</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dedeene</LastName><ForeName>Lieselot</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0545-8072</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Laboratory for Molecular Neurobiomarker Research and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Imaging and Pathology, Laboratory for Neuropathology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvaraj</LastName><ForeName>Bhuvaneish T</ForeName><Initials>BT</Initials><Identifier Source="ORCID">0000-0001-7299-0910</Identifier><AffiliationInfo><Affiliation>UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Euan MacDonald Centre, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandoorne</LastName><ForeName>Tijs</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madan</LastName><ForeName>Vanesa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Cell Biology, MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Blitterswijk</LastName><ForeName>Marka</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3054-7053</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raitcheva</LastName><ForeName>Denitza</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9003-9168</Identifier><AffiliationInfo><Affiliation>Biogen Idec, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCampbell</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1984-6052</Identifier><AffiliationInfo><Affiliation>Biogen Idec, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poesen</LastName><ForeName>Koen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Laboratory for Molecular Neurobiomarker Research and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gitler</LastName><ForeName>Aaron D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0001-8603-1526</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3713-8786</Identifier><AffiliationInfo><Affiliation>Hector Institute for Translational Brain Research, Central Institute of Mental Health, University of Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Reconstructive Neurobiology, Life &amp; Brain Center, University of Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanden Berghe</LastName><ForeName>Pieter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0009-2094</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Translational Research Centre for Gastrointestinal Disorders, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thal</LastName><ForeName>Dietmar Rudolf</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-1036-1075</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Imaging and Pathology, Laboratory for Neuropathology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verfaillie</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7564-4079</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Development and Regeneration, Stem Cell Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandran</LastName><ForeName>Siddharthan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Euan MacDonald Centre, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Development and Repair, inStem, Bangalore, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0104-4067</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bullock</LastName><ForeName>Simon L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0001-9491-4548</Identifier><AffiliationInfo><Affiliation>Division of Cell Biology, MRC Laboratory of Molecular Biology, Cambridge, UK. philip.vandamme@uzleuven.be sbullock@mrc-lmb.cam.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4010-2357</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium. philip.vandamme@uzleuven.be sbullock@mrc-lmb.cam.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_U105178790</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MEHTA/JUL17/948-795</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L023784/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R001162/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001370" MajorTopicYN="N">Axonal Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008870" MajorTopicYN="N">Microtubules</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>10</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33837088</ArticleId><ArticleId IdType="pmc">PMC8034861</ArticleId><ArticleId IdType="doi">10.1126/sciadv.abg3013</ArticleId><ArticleId IdType="pii">7/15/eabg3013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bang J., Spina S., Miller B. L., Frontotemporal dementia. Lancet 386, 1672&#x2013;1682 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P., Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 27, 1918&#x2013;1929 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I. R., Boeve B. F., Boxer A. L., Baker M., Rutherford N. J., Nicholson A. M., Finch N. C. A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G. Y. R., Karydas A., Seeley W. W., Josephs K. A., Coppola G., Geschwind D. H., Wszolek Z. K., Feldman H., Knopman D. S., Petersen R. C., Miller B. L., Dickson D. W., Boylan K. B., Graff-Radford N. R., Rademakers R., Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-Linked FTD and ALS. Neuron 72, 245&#x2013;256 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A. E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J. R., Schymick J. C., Laaksovirta H., van Swieten J. C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A. M., Kaganovich A., Scholz S. W., Duckworth J., Ding J., Harmer D. W., Hernandez D. G., Johnson J. O., Mok K., Ryten M., Trabzuni D., Guerreiro R. J., Orrell R. W., Neal J., Murray A., Pearson J., Jansen I. E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J. B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M. A., Peuralinna T., Jansson L., Isoviita V. M., Kaivorinne A. L., Holtta-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chio A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J. D., Sendtner M., Drepper C., Eichler E. E., Alkan C., Abdullaev Z., Pack S. D., Dutra A., Pak E., Hardy J., Singleton A., Williams N. M., Heutink P., Pickering-Brown S., Morris H. R., Tienari P. J., Traynor B. J., A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257&#x2013;268 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A. M., C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 14, 544&#x2013;558 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada S. B., Gendron T. F., Niccoli T., Genuth N. R., Grosely R., Shi Y., Glaria I., Kramer N. J., Nakayama L., Fang S., Dinger T. J. I., Thoeng A., Rocha G., Barna M., Puglisi J. D., Partridge L., Ichida J. K., Isaacs A. M., Petrucelli L., Gitler A. D., RPS25 is required for efficient RAN translation of C9orf72 and other neurodegenerative disease-associated nucleotide repeats. Nat. Neurosci. 22, 1383&#x2013;1388 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6713615</ArticleId><ArticleId IdType="pubmed">31358992</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Tan W., Westergard T., Krishnamurthy K., Markandaiah S. S., Shi Y., Lin S., Shneider N. A., Monaghan J., Pandey U. B., Pasinelli P., Ichida J. K., Trotti D., Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron 84, 1213&#x2013;1225 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I., Xiang S., Kato M., Wu L., Theodoropoulos P., Wang T., Kim J., Yun J., Xie Y., McKnight S. L., Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science 345, 1139&#x2013;1145 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gr&#xf6;nke S., Niccoli T., Ridler C. E., Clayton E. L., Devoy A., Moens T., Norona F. E., Woollacott I. O. C., Pietrzyk J., Cleverley K., Nicoll A. J., Pickering-brown S., Dols J., Cabecinha M., Hendrich O., Fratta P., Fisher E. M. C., Partridge L., Isaacs A. M., C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 345, 1192&#x2013;1194 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B. D., Lu Y., Lopez-Gonzalez R., Kim N. C., Almeida S., Lee K.-H., Badders N., Valentine M., Miller B. L., Wong P. C., Petrucelli L., Kim H. J., Gao F.-B., Taylor J. P., GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525, 129&#x2013;133 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x10d; A., Mertens J., Boeynaems S., Bogaert E., Chai N., Yamada S. B., Paul J. W., Sun S., Herdy J. R., Bieri G., Kramer N. J., Gage F. H., Van Den Bosch L., Robberecht W., Gitler A. D., Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 18, 1226&#x2013;1229 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran H., Almeida S., Moore J., Gendron T. F., Chalasani U. D., Lu Y., Du X., Nickerson J. A., Petrucelli L., Weng Z., Gao F. B., Differential toxicity of nuclear RNA foci versus dipeptide repeat proteins in a Drosophila model of C9ORF72 FTD/ALS. Neuron 87, 1207&#x2013;1214 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4589299</ArticleId><ArticleId IdType="pubmed">26402604</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D., Abdallah A., Li Z., Lu Y., Almeida S., Gao F. B., FTD/ALS-associated poly(GR) protein impairs the Notch pathway and is recruited by poly(GA) into cytoplasmic inclusions. Acta Neuropathol. 130, 525&#x2013;535 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4575383</ArticleId><ArticleId IdType="pubmed">26031661</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Michiels E., Gijselinck I., Sieben A., Jovi&#x10d;i&#x107; A., De Baets G., Scheveneels W., Steyaert J., Cuijt I., Verstrepen K. J., Callaerts P., Rousseau F., Schymkowitz J., Cruts M., Van Broeckhoven C., Van Damme P., Gitler A. D., Robberecht W., Van Den Bosch L., Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci. Rep. 6, 20877 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer N. J., Haney M. S., Morgens D. W., Jovi&#x10d;i&#x107; A., Couthouis J., Li A., Ousey J., Ma R., Bieri G., Tsui C. K., Shi Y., Hertz N. T., Tessier-lavigne M., Ichida J. K., Bassik M. C., Gitler A. D., CRISPR&#x2013;Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nat. Genet. 50, 603&#x2013;612 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893388</ArticleId><ArticleId IdType="pubmed">29507424</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Bento-Abreu A., Gendron T. F., Boeynaems S., Bogaert E., Nuyts R., Timmers M., Scheveneels W., Hersmus N., Wang J., Mizielinska S., Isaacs A. M., Petrucelli L., Lemmens R., Van Damme P., Van Den Bosch L., Robberecht W., A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 135, 427&#x2013;443 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T. F., Karydas A., Tran H., Yang D., Petrucelli L., Miller B. L., Almeida S., Gao F. B., Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron 92, 383&#x2013;391 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S. Y., Lopez-gonzalez R., Krishnan G., Phillips H. L., Li A. N., Seeley W. W., Yao W.-D., Almeida S., Gao F.-B., C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat. Neurosci. 22, 851&#x2013;862 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S., Lopez-Gonzalez R., Kunz R. C., Gangopadhyay J., Borufka C., Gygi S. P., Gao F. B., Reed R., Evidence that C9ORF72 dipeptide repeat proteins associate with U2 snRNP to cause mis-splicing in ALS/FTD patients. Cell Rep. 19, 2244&#x2013;2256 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5653973</ArticleId><ArticleId IdType="pubmed">28614712</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Yagi T., Cammack A. J., Mahadevan J., Kuroda M., Harms M. B., Miller T. M., Urano F., Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. Hum. Mol. Genet. 25, 1803&#x2013;1813 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986334</ArticleId><ArticleId IdType="pubmed">26931465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H., Hornburg D., Czuppa M., Bader J., Michaelsen M., Farny D., Arzberger T., Mann M., Meissner F., Edbauer D., Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity. Life Sci. Alliance 1, e201800070 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6238541</ArticleId><ArticleId IdType="pubmed">30456350</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens T. G., Niccoli T., Wilson K. M., Atilano M. L., Birsa N., Gittings L. M., Holbling B. V., Dyson M. C., Thoeng A., Neeves J., Glaria I., Yu L., Bussmann J., Storkebaum E., Pardo M., Choudhary J. S., Fratta P., Partridge L., Isaacs A. M., C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A. Acta Neuropathol. 137, 487&#x2013;500 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514073</ArticleId><ArticleId IdType="pubmed">30604225</ArticleId></ArticleIdList></Reference><Reference><Citation>V. Lafarga, O. Sirozh, I. D&#xed;az-L&#xf3;pez, M. Hisaoka, E. Zarzuela, J. Boskovic, B. Jovanovic, R. Fernandez-Leiro, J. Mu&#xf1;oz, G. Stoecklin, I. Ventoso, O. Fernandez-Capetillo, Generalized displacement of DNA- and RNA-binding factors mediates the toxicity of arginine-rich cell-penetrating peptides. bioRxiv 10.1101/441808 [Preprint]. 10 July 2019. 10.1101/441808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/441808</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C. J., Haeusler A. R., Grima J. C., Machamer J. B., Steinwald P., Daley E. L., Miller S. J., Cunningham K. M., Vidensky S., Gupta S., Thomas M. A., Hong I., Chiu S. L., Huganir R. L., Ostrow L. W., Matunis M. J., Wang J., Sattler R., Lloyd T. E., Rothstein J. D., The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525, 56&#x2013;61 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C. N., Wu Y., Odeh H. M., Gendron T. F., Jansen-West K., del Rosso G., Yue M., Jiang P., Gomes E., Tong J., Daughrity L. M., Avendano N. M., Castanedes-Casey M., Shao W., Oskarsson B., Tomassy G. S., McCampbell A., Rigo F., Dickson D. W., Shorter J., Zhang Y.-J., Petrucelli L., C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. Sci. Transl. Med. 12, eabb3774 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989020</ArticleId><ArticleId IdType="pubmed">32878979</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Kovacs D., Konijnenberg A., Timmerman E., Volkov A., Guharoy M., De Decker M., Jaspers T., Ryan V. H., Janke A. M., Baatsen P., Vercruysse T., Kolaitis R.-M., Daelemans D., Taylor J. P., Kedersha N., Anderson P., Impens F., Sobott F., Schymkowitz J., Rousseau F., Fawzi N. L., Robberecht W., Van Damme P., Tompa P., Van Den Bosch L., Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol. Cell 65, 1044&#x2013;1055.e5 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K. H., Zhang P., Kim H. J., Mitrea D. M., Sarkar M., Freibaum B. D., Cika J., Coughlin M., Messing J., Molliex A., Maxwell B. A., Kim N. C., Temirov J., Moore J., Kolaitis R. M., Shaw T. I., Bai B., Peng J., Kriwacki R. W., Taylor J. P., C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell 167, 774&#x2013;788.e17 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Mori E., Kato M., Xiang S., Wu L., Kwon I., McKnight S. L., Toxic PR poly-dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers. Cell 167, 789&#x2013;802.e12 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5076566</ArticleId><ArticleId IdType="pubmed">27768897</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A. E., Chi&#xf2; A., Traynor B. J., State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17, 17&#x2013;23 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B. N., Ticozzi N., Fallini C., Gkazi A. S., Topp S., Kenna K. P., Scotter E. L., Kost J., Keagle P., Miller J. W., Calini D., Vance C., Danielson E. W., Troakes C., Tiloca C., Al-Sarraj S., Lewis E. A., King A., Colombrita C., Pensato V., Castellotti B., de Belleroche J., Baas F., ten Asbroek A. L. M. A., Sapp P. C., McKenna-Yasek D., McLaughlin R. L., Polak M., Asress S., Esteban-P&#xe9;rez J., Mu&#xf1;oz-Blanco J. L., Simpson M.; SLAGEN Consortium, van Rheenen W., Diekstra F. P., Lauria G., Duga S., Corti S., Cereda C., Corrado L., Sorar&#xf9; G., Morrison K. E., Williams K. L., Nicholson G. A., Blair I. P., Dion P. A., Leblond C. S., Rouleau G. A., Hardiman O., Veldink J. H., Van Den Berg L. H., Al-Chalabi A., Pall H., Shaw P. J., Turner M. R., Talbot K., Taroni F., Garc&#xed;a-Redondo A., Wu Z., Glass J. D., Gellera C., Ratti A., Brown R. H. Jr., Silani V., Shaw C. E., Landers J. E., D&#x2019;Alfonso S., Mazzini L., Comi G. P., Del Bo R., Ceroni M., Gagliardi S., Querin G., Bertolin C., Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron 84, 324&#x2013;331 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521390</ArticleId><ArticleId IdType="pubmed">25374358</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K. P., Renton A. E., Ticozzi N., Faghri F., Chia R., Dominov J. A., Kenna B. J., Nalls M. A., Keagle P., Rivera A. M., van Rheenen W., Murphy N. A., van Vugt J. J. F. A., Geiger J. T., Van der Spek R. A., Pliner H. A., Shankaracharya, Smith B. N., Marangi G., Topp S. D., Abramzon Y., Gkazi A. S., Eicher J. D., Kenna A.; ITALSGEN Consortium, Mora G., Calvo A., Mazzini L., Riva N., Mandrioli J., Caponnetto C., Battistini S., Volanti P., Bella V. L., Conforti F. L., Borghero G., Messina S., Simone I. L., Trojsi F., Salvi F., Logullo F. O., D&#x2019;Alfonso S., Corrado L., Capasso M., Ferrucci L.; Genomic Translation for ALS Care (GTAC) Consortium, de Araujo Martins Moreno C., Kamalakaran S., Goldstein D. B.; ALS Sequencing Consortium, Gitler A. D., Harris T., Myer R. M.; NYGC ALS Consortium, Phatnani H., Musunuri R. L., Evani U. S., Abhyankar A., Zody M. C.; Answer ALS Foundation, Kaye J., Finkbeiner S., Wyman S. K., Nail A. L., Lima L., Fraenkel E., Svendsen C. N., Thompson L. M., Van Eyk J. E., Berry J. D., Miller T. M., Kolb S. J., Cudkowicz M., Baxi E.; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, Benatar M., Taylor J. P., Rampersaud E., Wu G., Wuu J.; SLAGEN Consortium, Lauria G., Verde F., Fogh I., Tiloca C., Comi G. P., Sorar&#xf9; G., Cereda C.; French ALS Consortium, Corcia P., Laaksovirta H., Myllykangas L., Jansson L., Valori M., Ealing J., Hamdalla H., Rollinson S., Pickering-Brown S., Orrell R. W., Sidle K. C., Malaspina A., Hardy J., Singleton A. B., Johnson J. O., Arepalli S., Sapp P. C., McKenna-Yasek D., Polak M., Asress S., Al-Sarraj S., King A., Troakes C., Vance C., de Belleroche J., Baas F., Ten Asbroek A. L. M. A., Mu&#xf1;oz-Blanco J. L., Hernandez D. G., Ding J., Gibbs J. R., Scholz S. W., Floeter M. K., Campbell R. H., Landi F., Bowser R., Pulst S. M., Ravits J. M., MacGowan D. J. L., Kirby J., Pioro E. P., Pamphlett R., Broach J., Gerhard G., Dunckley T. L., Brady C. B., Kowall N. W., Troncoso J. C., Ber I. L., Mouzat K., Lumbroso S., Heiman-Patterson T. D., Kamel F., Van Den Bosch L., Baloh R. H., Strom T. M., Meitinger T., Shatunov A., Van Eijk K. R., de Carvalho M., Kooyman M., Middelkoop B., Moisse M., McLaughlin R. L., Van Es M. A., Weber M., Boylan K. B., Van Blitterswijk M., Rademakers R., Morrison K. E., Basak A. N., Mora J. S., Drory V. E., Shaw P. J., Turner M. R., Talbot K., Hardiman O., Williams K. L., Fifita J. A., Nicholson G. A., Blair I. P., Rouleau G. A., Esteban-P&#xe9;rez J., Garc&#xed;a-Redondo A., Al-Chalabi A.; Project Min E ALS Sequencing Consortium, Rogaeva E., Zinman L., Ostrow L. W., Maragakis N. J., Rothstein J. D., Simmons Z., Cooper-Knock J., Brice A., Goutman S. A., Feldman E. L., Gibson S. B., Taroni F., Ratti A., Gellera C., Van Damme P., Robberecht W., Fratta P., Sabatelli M., Lunetta C., Ludolph A. C., Andersen P. M., Weishaupt J. H., Camu W., Trojanowski J. Q., Van Deerlin V. M., Brown R. H. Jr., van den Berg L. H., Veldink J. H., Harms M. B., Glass J. D., Stone D. J., Tienari P., Silani V., Chi&#xf2; A., Shaw C. E., Traynor B. J., Landers J. E., Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron 97, 1268&#x2013;1283.e6 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C., Sedlmeier R., Meyer T., Homberg V., Sperfeld A. D., Kurt A., Prudlo J., Peraus G., Hanemann C. O., Stumm G., Ludolph A. C., Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63, 724&#x2013;726 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15326253</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj B. T., Livesey M. R., Zhao C., Gregory J. M., James O. T., Cleary E. M., Chouhan A. K., Gane A. B., Perkins E. M., Dando O., Lillico S. G., Lee Y. B., Nishimura A. L., Poreci U., Thankamony S., Pray M., Vasistha N. A., Magnani D., Borooah S., Burr K., Story D., McCampbell A., Shaw C. E., Kind P. C., Aitman T. J., Whitelaw C. B. A., Wilmut I., Smith C., Miles G. B., Hardingham G. E., Wyllie D. J. A., Chandran S., C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity. Nat. Commun. 9, 347 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5783946</ArticleId><ArticleId IdType="pubmed">29367641</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Devlin A., Chouhan A. K., Selvaraj B. T., Stavrou M., Burr K., Story D., Brivio V., He X., Mehta A. R., Shaw C. E., Dando O., Hardingham G. E., Miles G. B., Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia 68, 1046&#x2013;1064 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Stoklund Dittlau K., Van Den Bosch L., Axonal transport defects and neurodegeneration: Molecular mechanisms and therapeutic implications. Semin. Cell Dev. Biol. 99, 133&#x2013;150 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31542222</ArticleId></ArticleIdList></Reference><Reference><Citation>Vagnoni A., Hoffmann P. C., Bullock S. L., Reducing Lissencephaly-1 levels augments mitochondrial transport and has a protective effect in adult Drosophila neurons. J. Cell Sci. 129, 178&#x2013;190 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4732301</ArticleId><ArticleId IdType="pubmed">26598558</ArticleId></ArticleIdList></Reference><Reference><Citation>van Spronsen M., Mikhaylova M., Lipka J., Schlager M. A., van den Heuvel D. J., Kuijpers M., Wulf P. S., Keijzer N., Demmers J., Kapitein L. C., Jaarsma D., Gerritsen H. C., Akhmanova A., Hoogenraad C. C., TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites. Neuron 77, 485&#x2013;502 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23395375</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami N. H., Smith R. B., Carrasco M. A., Williams L. A., Winborn C. S., Han S. S. W., Kiskinis E., Winborn B., Freibaum B. D., Kanagaraj A., Clare A. J., Badders N. M., Bilican B., Chaum E., Chandran S., Shaw C. E., Eggan K. C., Maniatis T., Taylor J. P., Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81, 536&#x2013;543 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxton W. M., Hollenbeck P. J., The axonal transport of mitochondria. J. Cell Sci. 125, 2095&#x2013;2104 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3656622</ArticleId><ArticleId IdType="pubmed">22619228</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I. R. A., Frick P., Gr&#xe4;sser F. A., Gendron T. F., Petrucelli L., Cashman N. R., Edbauer D., Kremmer E., Prudlo J., Troost D., Neumann M., Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. 130, 845&#x2013;861 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S., Stauffer J. E., Jiang J., Garcia S. D., Amy E., Schulte D., Ohkubo T., Schloffman C. L., Maldonado M., Baughn M., Rodriguez M. J., Pizzo D., Cleveland D., Ravits J., Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. 135, 459&#x2013;474 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandopulle M. S., Lippincott-Schwartz J., Ward M. E., RNA transport and local translation in neurodevelopmental and neurodegenerative disease. Nat. Neurosci., (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33510479</ArticleId></ArticleIdList></Reference><Reference><Citation>Woehlke G., Ruby A. K., Hart C. L., Ly B., Hom-Booher N., Vale R. D., Microtubule interaction site of the kinesin motor. Cell 90, 207&#x2013;216 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9244295</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter A. P., Diamant A. G., Urnavicius L., How dynein and dynactin transport cargos: A structural perspective. Curr. Opin. Struct. Biol. 37, 62&#x2013;70 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26773477</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Sheetz M. P., The C-terminus of tubulin increases cytoplasmic dynein and kinesin processivity. Biophys. J. 78, 1955&#x2013;1964 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1300788</ArticleId><ArticleId IdType="pubmed">10733974</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Naujock M., Fumagalli L., Vandoorne T., Baatsen P., Boon R., Ordov&#xe1;s L., Patel A., Welters M., Vanwelden T., Geens N., Tricot T., Benoy V., Steyaert J., Lefebvre-Omar C., Boesmans W., Jarpe M., Sterneckert J., Wegner F., Petri S., Bohl D., Vanden Berghe P., Robberecht W., Van Damme P., Verfaillie C., Van Den Bosch L., HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun. 8, 864 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N., Pal A., Lojewski X., Corcia P., Naujock M., Reinhardt P., Sterneckert J., Petri S., Wegner F., Storch A., Hermann A., Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol. Dis. 115, 167&#x2013;181 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Burk K., Pasterkamp R. J., Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathol. 137, 859&#x2013;877 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531423</ArticleId><ArticleId IdType="pubmed">30721407</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo-Rady M., Kalmbach N., Pal A., Schludi C., Janosch A., Richter T., Freitag P., Bickle M., Kahlert A. K., Petri S., Stefanov S., Glass H., Staege S., Just W., Bhatnagar R., Edbauer D., Hermann A., Wegner F., Sterneckert J. L., Knocking out C9ORF72 exacerbates axonal trafficking defects associated with hexanucleotide repeat expansion and reduces levels of heat shock proteins. Stem Cell Rep. 14, 390&#x2013;405 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7066330</ArticleId><ArticleId IdType="pubmed">32084385</ArticleId></ArticleIdList></Reference><Reference><Citation>Woollacott I. O. C., Mead S., The C9ORF72 expansion mutation: Gene structure, phenotypic and diagnostic issues. Acta Neuropathol. 127, 319&#x2013;332 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24515836</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin K. R., Godena V. K., Hewitt V. L., Whitworth A. J., Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum. Mol. Genet. 25, 2378&#x2013;2392 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5181624</ArticleId><ArticleId IdType="pubmed">27056981</ArticleId></ArticleIdList></Reference><Reference><Citation>Janke C., Magiera M. M., The tubulin code and its role in controlling microtubule properties and functions. Nat. Rev. Mol. Cell Biol. 21, 307&#x2013;326 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32107477</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit R., Ross J. L., Goldman Y. E., Holzbaur E. L. F., Differential regulation of dynein and kinesin motor proteins by Tau. Science 319, 1086&#x2013;1089 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2866193</ArticleId><ArticleId IdType="pubmed">18202255</ArticleId></ArticleIdList></Reference><Reference><Citation>Paonessa F., Evans L. D., Solanki R., Hardy J., Jackson S. P., Livesey F. J., Paonessa F., Evans L. D., Solanki R., Larrieu D., Wray S., Hardy J., Jackson S. P., Livesey F. J., Microtubules deform the nuclear membrane and disrupt nucleocytoplasmic transport in Tau-mediated frontotemporal dementia. Cell Rep. 26, 582&#x2013;593.e5 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6335264</ArticleId><ArticleId IdType="pubmed">30650353</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbier P., Zejneli O., Martinho M., Lasorsa A., Belle V., Smet-Nocca C., Tsvetkov P. O., Devred F., Landrieu I., Role of tau as a microtubule-associated protein: Structural and functional aspects. Front. Aging Neurosci. 10, 204 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6692637</ArticleId><ArticleId IdType="pubmed">31447664</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A. R., Gregory J. M., Dando O., Carter R. N., Burr K., Nanda J., Story D., McDade K., Smith C., Morton N. M., Mahad D. J., Hardingham G. E., Chandran S., Selvaraj B. T., Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis. Acta Neuropathol. 141, 257&#x2013;279 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847443</ArticleId><ArticleId IdType="pubmed">33398403</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y., Piskorowski R. A., Salah-Mohellibi N., Chevaleyre V., Peschanski M., Martinat C., Nedelec P., Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat. Biotechnol. 33, 89&#x2013;98 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Blitterswijk M., Dejesus-hernandez M., Niemantsverdriet E., Murray M. E., Heckman M. G., Diehl N. N., Brown P. H., Baker M. C., Finch N. C. A., Bauer P. O., Serrano G., Beach T. G., Josephs K. A., Knopman D. S., Petersen R. C., Boeve B. F., Graff N. R., Boylan K. B., Petrucelli L., Dickson D. W., Rademakers R., Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): A cross-sectional cohort study. Lancet Neurol. 12, 978&#x2013;988 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3879782</ArticleId><ArticleId IdType="pubmed">24011653</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ydewalle C., Krishnan J., Chiheb D. M., Van Damme P., Irobi J., Kozikowski A. P., Vanden Berghe P., Timmerman V., Robberecht W., Van Den Bosch L., HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1&#x2013;induced Charcot-Marie-Tooth disease. Nat. Med. 17, 968&#x2013;974 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21785432</ArticleId></ArticleIdList></Reference><Reference><Citation>Brendza K. M., Rose D. J., Gilbert S. P., Saxton W. M., Lethal kinesin mutations reveal amino acids important for ATPase activation and structural coupling. J. Biol. Chem. 274, 31506&#x2013;31514 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3204605</ArticleId><ArticleId IdType="pubmed">10531353</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y., Soares L., Teng X., Geary M., Bonini N. M., A novel Drosophila model of nerve injury reveals an essential role of Nmnat in maintaining axonal integrity. Curr. Biol. 22, 590&#x2013;595 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3347919</ArticleId><ArticleId IdType="pubmed">22425156</ArticleId></ArticleIdList></Reference><Reference><Citation>Port F., Chen H. M., Lee T., Bullock S. L., Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 111, E2967&#x2013;E2976 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4115528</ArticleId><ArticleId IdType="pubmed">25002478</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J., Hein M. Y., Luber C. A., Paron I., Nagaraj N., Mann M., Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics 13, 2513&#x2013;2526 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159666</ArticleId><ArticleId IdType="pubmed">24942700</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlager M. A., Hoang H. T., Urnavicius L., Bullock S. L., Carter A. P., In vitro reconstitution of a highly processive recombinant human dynein complex. EMBO J. 33, 1855&#x2013;1868 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4158905</ArticleId><ArticleId IdType="pubmed">24986880</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomishige M., Vale R. D., Controlling kinesin by reversible disulfide cross-linking: Identifying the motility-producing conformational change. J. Cell Biol. 151, 1081&#x2013;1092 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2174365</ArticleId><ArticleId IdType="pubmed">11086009</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., De Decker M., Tompa P., Van Den Bosch L., Arginine-rich peptides can actively mediate liquid-liquid phase separation. Bio-Protocol 7, e2525 (2017).</Citation></Reference><Reference><Citation>Almeida S., Gascon E., Tran H., Chou H. J., Gendron T. F., Degroot S., Tapper A. R., Sellier C., Charlet-Berguerand N., Karydas A., Seeley W. W., Boxer A. L., Petrucelli L., Miller B. L., Gao F. B., Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 126, 385&#x2013;399 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3753484</ArticleId><ArticleId IdType="pubmed">23836290</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>